Verseon Presents Data on a New Class of Anti-coagulants at the 8th Biotech Showcase Conference
Verseon (AIM: VSN). Dr. David Kita, Verseon’s co-founder and Vice President of Research and Development, presented preclinical data on the company’s new class of anti-coagulants at the 8th annual Biotech Showcase yesterday - January 12th.
2016-01-13 Ringier Nonwovens

iConnectHub
Login/Register
Supplier Login











Home












